Title:
HER3 BINDING PROTEIN AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/165475
Kind Code:
A1
Abstract:
Provided are an HER3 binding protein and use thereof. Specifically, provided are an anti-HER3 antibody or an antigen-binding fragment thereof, nucleic acid molecules encoding same, and a method for preparing same. The anti-HER3 antibody or the antigen-binding fragment thereof has high specificity and high affinity for HER3 and does not bind to EGFR, HER2, and HER4 of the same family. Further provided is use of the antibody or the antigen-binding fragment thereof in the treatment and diagnosis of disease.
Inventors:
HU JIANGJIANG (CN)
BAI YUN (CN)
LONG HU (CN)
YUAN XIAOXI (CN)
BAI YUN (CN)
LONG HU (CN)
YUAN XIAOXI (CN)
Application Number:
PCT/CN2023/078774
Publication Date:
September 07, 2023
Filing Date:
February 28, 2023
Export Citation:
Assignee:
SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD (CN)
International Classes:
C07K16/32; A61K39/395; A61P35/00
Foreign References:
| US20200207868A1 | 2020-07-02 | |||
| CN101365723A | 2009-02-11 | |||
| CN104093743A | 2014-10-08 | |||
| CN105999263A | 2016-10-12 | |||
| CN108341873A | 2018-07-31 | |||
| CN110167968A | 2019-08-23 | |||
| CN110760003A | 2020-02-07 | |||
| CN111228511A | 2020-06-05 |
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF:
Previous Patent: CARRYING TROLLEY
Next Patent: POLYPEPTIDE COMPOUND SPECIFICALLY TARGETING SORT1, AND DRUG CONJUGATE THEREOF
Next Patent: POLYPEPTIDE COMPOUND SPECIFICALLY TARGETING SORT1, AND DRUG CONJUGATE THEREOF